In the Media

Emyria in the Australian Financial Review on the future of psychedelics
Jan 18, 2023

Emyria in the Australian Financial Review on the future of psychedelics

Emyria Clinical E-Registry study into oral Medicinal Cannabis featured in the media
Nov 23, 2022

Emyria Clinical E-Registry study into oral Medicinal Cannabis featured in the media

Emyria & PsychoGenics collaboration in PharmaVoice
Oct 12, 2022

Emyria & PsychoGenics collaboration in PharmaVoice

Emyria featured in The Australian’s biotech Investor Guide
Sep 29, 2022

Emyria featured in The Australian’s biotech Investor Guide

Dr Michael Winlo discusses future of psychedelics with SMH
May 17, 2022

Dr Michael Winlo discusses future of psychedelics with SMH

Emyria featured in ‘The West Australian’
May 10, 2022

Emyria featured in ‘The West Australian’

Opinion | Psychedelic substances represent a chance to alleviate Australia’s mental health crisis
Mar 20, 2021

Opinion | Psychedelic substances represent a chance to alleviate Australia’s mental health crisis

Emyria’s Managing Director speaks on the obstacles within the industry
Jan 20, 2021

Emyria’s Managing Director speaks on the obstacles within the industry

Have Questions?

If you have any question, please feel free to get in touch with us.

Contact Us

Hit enter to search or ESC to close

Call 08 6559 2800Contact